News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
Biotech/Pharma - Alliances
Sigma-Aldrich Corporation (SIAL), University of Michigan Medical School Establish CRISPR Core Lab Partnership 9/18/2014
Spring Bank Pharmaceuticals, Inc. Announces National Institutes of Health (NIH) Collaboration For Testing Of SB 9200 Against Multiple Viral Pathogens 9/18/2014
Iliad Neurosciences, Inc. Enters Into An Exclusive License Agreement With The Research Foundation For The State University Of New York 9/18/2014
Galen Signs Exclusive Deal In Europe 9/18/2014
Merck KGaA (MKGAF.PK) Wants Bids For Cancer Therapy Partners 9/18/2014
Spectrum Pharmaceuticals, Inc. (SPPI) Out-Licenses Rights For Greater China To CASI Pharmaceuticals  (ENMD) For Three Of Its Drugs 9/18/2014
Innovus Pharma Signs Exclusive Marketing Sales And Distribution Agreement With Tramorgan Limited To Market And Distribute Sensum+™ In The United Kingdom 9/18/2014
Boehringer Ingelheim Corporation Will Pay Up To $600 Million For CureVac GmbH Lung Cancer Vaccine 9/18/2014
Biocryst Pharmaceuticals (BCRX) Receives Additional National Institute of Allergy And Infectious Diseases (NIAID) Funding For Manufacture And Development Of BCX4430 To Treat Hemorrhagic Virus Diseases 9/18/2014
South San Francisco's Sutro Biopharma Forges $375 Million Antibody Drug Pact With Merck KGaA (MKGAF.PK) 9/17/2014
The Michael J. Fox Foundation Forms New Partnership With The Bachmann-Strauss Dystonia And Parkinson Foundation 9/17/2014
Protein Sciences Corporation And Diamyd Medical AB Deepen Commitment To Develop New Treatment For Diabetes 9/17/2014
CTI BioPharma And Servier Announce Exclusive License And Collaboration Agreement To Develop And Commercialize Pixuvri® 9/17/2014
3SBio Inc. (SSRX) Obtains Exclusive Licenses To Develop And Market Jenkem's PEG-Irinotecan In China 9/17/2014
Champions Oncology, Inc. (CSBR) Partners With Sarcoma Alliance To Bring Personalized Treatment Options To Sarcoma Patients 9/17/2014
NuView Life Sciences Inc. Enters Global Licensing Agreement With Otsuka Pharmaceutical Co., Ltd. 9/17/2014
PharmaVentures Ltd Advises MedGenesis Therapeutix In Agreement For Its Potential Therapy For Parkinson's Disease. 9/17/2014
Hetero Enters License Agreement With Gilead Sciences, Inc. (GILD), U.S.A. To Produce Generic Sofosbuvir For Treatment Of Chronic Hepatitis C 9/17/2014
Metabolon's Quantose™ Prediabetes Tests Now Available in Europe Through Collaboration With Metdia Biotech 9/17/2014
Bay Area Startup MyoKardia Forges $200 Million Heart Disease Pact With Sanofi (France) (SAN.PA) 9/17/2014
Elevance Expands Customer Service And Support Capabilities With E-360 Collaboration 9/17/2014
Covance Inc. (CVD) And Frenova Renal Research Establish Innovative Research Collaboration 9/17/2014
Isis Pharmaceuticals, Inc. (ISIS) Earns $4 Million From Achaogen (AKAO) For The Initiation Of A Phase 3 Study Of Plazomicin 9/17/2014
Aspen Institute Launches New Partnership with Friends of Cancer Research 9/17/2014
Eli Lilly and Company (LLY) Bets $500 Million On AstraZeneca PLC (AZN)’s Alzheimer's Drug 9/16/2014
Gilead Sciences, Inc. (GILD) Says Indian Firms May Sell Generics of Hep C Drug Sovaldi 9/16/2014
Curie-Cancer And Inventiva Announce A Partnership In Epigenetics For The Treatment Of Cancer 9/16/2014
Relmada Therapeutics Enters Into Agreement With Memorial Sloan-Kettering Cancer Center To Better Clarify Unique Mechanism Of Action For LevoCap ER 9/16/2014
Google Inc.-Backed Calico Announces Plan To Combat ALS, Parkinson's 9/16/2014
GlaxoSmithKline (GSK) Exercises Option For Five Prime Therapeutics, Inc. (FPRX)'s Skeletal Muscle Drugs 9/16/2014
Galen Signs Exclusive Deal in Europe 9/16/2014
Lupin Ltd. (LUPN.BO), Merck Serono Forge Emerging Markets Pact; Deal Could Add Up To 20 Drugs To Merck's Portfolio 9/16/2014
PHARNEXT And The Hereditary Neuropathy Foundation Collaborate To Increase Awareness Of Charcot-Marie-Tooth Disease 9/16/2014
Axxess Pharma, Inc. Expands Global License Agreement With ABG TapouT To Include Several New High Demand Products 9/16/2014
JDRF And Tidepool Partner To Bring Data To An Open Source Platform For People With Type 1 Diabetes 9/16/2014
WellDoc And American Diabetes Association's Maryland Chapter Announce A New Collaboration To Empower People With Type 2 Diabetes To Manage Their Condition 9/16/2014
Cannabis Science Inc. And Unistraw Holdings Join Forces To Produce Proprietary Formulations Delivering A Wide Array Of Unique Cannabis Extracts And Pure Cannabinoid-Based Products 9/16/2014
Coldstream Laboratories Inc. Partners With CytImmune Sciences Inc. For Phase 2 Sterile Manufacturing 9/16/2014
NantBioscience And University of Colorado To Collaborate On Development Of Novel Protein Cancer Fighting Drugs 9/15/2014
Evotec AG (EVTG.F) And The Jain Foundation Expand Collaboration: Start Of Multiple Drug Screening Programmes 9/15/2014
Mylan Inc. (MYL) Signs Agreement With Gilead Sciences, Inc. (GILD) To Accelerate Access To Hepatitis C Treatments, Sovaldi® (Sofosbuvir) And Single Tablet Regimen Of Ledipasvir/Sofosbuvir, in Developing Countries 9/15/2014
BioHealth Innovation Signs Agreement With Roche (RHHBY) To Source Technologies For Research, Development And Commercialization 9/15/2014
Internet Scientific Publications Partners With UBM Medica US 9/15/2014
Simulations Plus (SLP) Wins Cooperative Agreement With FDA 9/15/2014
Cellprothera® And BioCardia Partner On Phase 2 EXCELLENT Trial 9/15/2014
Advanced Biological Laboratories SA (ABL) Enters Promotional Agreement With Abbott Laboratories (ABT) For Innovative Software Suite In HIV Genotyping 9/15/2014
HUYA Bioscience International And TIPR Announce Joint Venture To Develop Medical Innovation For Global Markets 9/15/2014
BeiGene Co.,Ltd Receives Clinical Milestone Payment For Development Of BGB-290 9/15/2014
Lupin Ltd. (LUPN.BO) May Sign $1.5 Billion Deal With Merck Serono; Lupin Stock Hits A New High 9/15/2014
Dad Turned Biotech CEO Inks Drug Testing Deal With Pfizer (PFE) 9/12/2014
BGI And The Vancouver Prostate Centre Announce Partnership To Create Joint Research Laboratory For Advancement Of Translational Cancer Research 9/12/2014
Bay Area's Cellerant Therapeutics, Inc. Awarded $47.5 Million From The U.S. Government 9/11/2014
Mimetogen Pharmaceuticals Announces Expiration Of Exclusive Option Agreement With Bausch & Lomb 9/11/2014
NeuroVive Pharmaceutical AB: Addendum: Oncore License 9/11/2014
BioInvent (BOVNF) Receives Another Milestone Payment From Bayer In Connection With Start Of A Phase I Trial 9/11/2014
ProPhase Labs, Inc. (Formerly Known as Quigley Corporation) (QGLY) Expects To Report A $3.6 Million Impairment Charge Relating To Its Phusion Joint Venture 9/11/2014
Evotec AG (EVTG.F) And CHDI, Inc. Foundation Extend Ongoing Collaboration To Fight Huntington's Disease 9/11/2014
ChromaDex, Inc. And Healthy Directions Enter Into NIAGEN™ Supply Agreement 9/11/2014
Cancer Research UK, Cancer Research Technology And Asterias Biotherapeutics Partner To Trial Immunotherapy Vaccine For Lung Cancer 9/11/2014
Cerus Corporation (CERS) And Biomedica Foscama Group S.P.A. Enter Distribution Agreement For The INTERCEPT Blood System In Italy 9/11/2014
Sophia Genetics Announces First Deal With Britain's NHS And Leading Turkish Laboratory, Expanding European Customer Base 9/11/2014
Medivation, Inc. (MDVN) Banks $90 Million From Astellas Pharma Inc. (ALPMY) As FDA Expands Use Of Prostate Cancer Drug 9/10/2014
Shenzhen Beike Biotechnology Co. Ltd., Altor BioScience Corporation Strike $200 Million Cancer Deal 9/10/2014
Seattle Genetics, Inc. (SGEN), Genmab A/S (GEN.CO) Partner In $211 Million Antibody-Drug Pact 9/10/2014
Hemispherx Biopharma (HEB) And The Swiss Department Of Defense, Civil Protection And Sports Expand Their Collaborative Research Agreement To Include The Study Of Alferon® And Ampligen® Against The Ebola Virus 9/10/2014
MabVax Therapeutics, Inc. Enters Agreements With Memorial Sloan-Kettering Cancer Center And Juno Therapeutics For Development Of Anti-Cancer Therapeutics 9/10/2014
Inocucor Technologies Signs First Commercial Strategic Partnership With Axter Agroscience 9/10/2014
Sectra (SECTB) Joins HIMSS Innovation Center As A Supporting Collaborator 9/10/2014
EMD Group (EMD Millipore (Massachusetts)) And Accelerated Cure Project Launch Collaborative Research Program To Optimize Treatment And Understand Progression Of Multiple Sclerosis 9/10/2014
Mettler-Toledo (MTD) Release: New Pharmaceutical Solid Dosage Form Development Collaboration 9/10/2014
Medidata Solutions, Inc. And ICON Join Forces To Bring New Productivity To Capturing Patient Voice In Clinical Trials 9/10/2014
University of Minnesota Masonic Cancer Center Joins CEL-SCI (CVM)’s Phase 3 Head & Neck Cancer Trial 9/10/2014
Trialbee Helps AstraZeneca PLC (AZN) Reduce The Time Required For Recruitment Of Patients To Clinical Trials 9/10/2014
PharmAthene, Inc. (PIP) Awarded Contract Of Up To $28.1 Million To Develop Next Generation Thermostable Anthrax Vaccine 9/10/2014
XenoPort, Inc. (XNPT) And The NIAAA Announce Clinical Trial Agreement To Study HORIZANT As A Potential Treatment For Alcohol Use Disorder 9/9/2014
Ligand Pharmaceuticals Inc. (LGND) Licenses Captisol-Enabled™ Lamotrigine To CURx Pharmaceuticals 9/9/2014
SRI International And Nobelpharma, Partner On Endometriosis Drug Development 9/9/2014
Mayo Clinic And Delos®, The Pioneer Of Wellness Real Estate™, Announce Agreement To Establish The WELL Living Lab 9/9/2014
Emergent BioSolutions (EBS) Awarded $29 Million Contract To Develop A Dry Formulation Of Nuthrax 9/9/2014
Cempra Pharmaceuticals, Inc. Gets $10 Million Milestone Payment From Toyama Chemical Company 9/9/2014
NeuroVive Pharmaceutical AB, Oncore Sign $150 Million Hepatitis B Pact 9/9/2014
Relypsa, Inc. (RLYP) Announces Commercial Manufacturing Agreement With Patheon Inc. (PTI.TO) 9/9/2014
Oncore Licenses Second-Generation Cyclophilin Inhibitors From Neurovive For The Treatment Of Chronic HBV Infection 9/9/2014
genae Opens Offices In Dubai And Announces Collaboration With Leading Gulf Clinicians 9/9/2014
Sutro Biopharma To Collaborate With University of California, San Francisco (UCSF), A Recombinant Antibody Network (RAN) Member 9/9/2014
Google Inc.'s Startup Calico Forges Pact With AbbVie (ABBV), New R&D Facility In San Francisco 9/9/2014
Ophthotech Corporation (OPHT) Banks $50 Million Milestone From Novartis AG (NVS) For Fovista® Pact 9/8/2014
Schrödinger And Tri-Institutional Therapeutics Discovery Institute Announce Agreement To Provide Drug Discovery Software To Tri-Institutional Researchers 9/8/2014
Lee's Pharm In-licenses Second Product From Italy's Abiogen Pharma 9/8/2014
Emergent BioSolutions (EBS) Awarded Contract To Develop A Dry Formulation Of Nuthrax, A Next Generation Anthrax Vaccine 9/8/2014
Venus Remedies Ties It Up With Mylan Inc. (MYL) For Marketing Meropenem In Three European Countries 9/8/2014
Janssen Pharmaceutical Inc. And Johnson & Johnson (JNJ) Innovation Establish Research Collaboration With The University of Toronto 9/8/2014
Innovus Pharma Expands US Distribution By Signing A Non-Exclusive Sampling And Distribution Agreement With Bulu Box® For Zestra® In The U.S. 9/8/2014
Hemispherx Biopharma (HEB) And United States Army Medical Research Institute Of Infectious Diseases (USAMRIID) Agree To Collaborate In Studying Alferon® And Ampligen® Against The Ebola Virus 9/8/2014
Zhejiang Huahai And Tianjin Pharma To Form U.S.-Aimed Partnership 9/8/2014
PeriGen Announces Partnership With University Of Utah Hospital For PeriCALM Evidence-based Fetal Strip Interpretation 9/8/2014
PharmAthene, Inc. (PIP) And Nanotherapeutics Form Strategic Alliance To Advance Biodefense Programs 9/8/2014
Pharmatech, Inc. Announces Research Collaboration Under Phase II National Cancer Institute/SBIR Grant With Weill Cornell Medical College 9/8/2014
Mayo Clinic And IBM Task Watson To Improve Clinical Trial Research 9/8/2014
University of Toronto Announces Strategic Collaboration With Janssen Inc. And Johnson & Johnson Innovation (JNJ) 9/8/2014
Almac Group Forms Academia-Industry Collaboration To Develop Green Chemicals 9/8/2014
Solentim Ltd Embraces CRISPR And Other Rapid Gene-Editing Technologies With Horizon Discovery Ltd. 9/8/2014
PharmAthene, Inc. (PIP) And Nanotherapeutics Form Strategic Alliance To Advance Biodefense Programs 9/8/2014
Gilead Sciences, Inc. (GILD) Close To Inking Deal That Would Bring Low-Cost Versions Of $84,000 Solvadi Drug To Poor Countries 9/5/2014
AbbVie (ABBV) Hands Over $275 Million Upfront For Infinity Pharmaceuticals Inc. (INFI)’s Blood Cancer Drug; Deal Could Be Worth $805 Million 9/5/2014
Pfizer Inc. (PFE) Strikes Pact To Market Novartis AG (NVS)'s Respiratory Inhalers In The UK 9/5/2014
Earlier Tumour Diagnosis With Advanced Ultrasound Technology From Oxford University 9/5/2014
Hainan Sinotau In-Licenses Radiopharmaceutical From Navidea Biopharmaceuticals (NAVB) Of The U.S. 9/5/2014
Tiny Redx Pharma Signs "Transformational" Cancer Deal With AstraZeneca PLC (AZN); Financial Terms Have Not Been Disclosed 9/4/2014
Metabolon And Baylor College of Medicine Partner To Launch Global Metabolomic-Assisted Pathway Screen (MAPS) For Inborn Errors Of Metabolism 9/4/2014
Bavarian Nordic (BAVA.CO) Accelerates Ebola Vaccine Development Programs In Collaboration With The National Institutes of Health (NIH) 9/4/2014
Abcam plc (ABC.L) And Cell Marque Sign Global Strategic Marketing Agreement For IVD IHC RabMAb Antibodies 9/4/2014
Masters Speciality Pharma Enters Agreement With ApoPharma 9/4/2014
Navidea Biopharmaceuticals (NAVB) Enters Lymphoseek® Development And Commercialization Agreement For China 9/4/2014
SELLAS Life Sciences Group Signs Exclusive License Agreement For Global Rights On Development And Commercialization Of WT1 Cancer Vaccine With Memorial Sloan-Kettering Cancer Center 9/4/2014
Vectura Group plc (VEC.L) Release: Announcement Of Commercial Arrangement With Pfizer Inc. (PFE) UK To Promote Ultibro® Breezhaler® And Seebri® Breezhaler® In The United Kingdom 9/4/2014
Shionogi & Co., Ltd. Enlists BuzzeoPDMA, A Cegedim Company To Support Their Sample Management Compliance Programs 9/4/2014
BeiGene Co.,Ltd Signs China CMO Deal With Boehringer Ingelheim Corporation 9/4/2014
Zoetis (ZTS) Granted Conditional License For Porcine Epidemic Diarrhea Vaccine* 9/3/2014
Palatin Technologies (PTN) Licenses Bremelanotide In Europe And Other Selected Countries To Gedeon Richter Ltd. (RIG2.F) 9/3/2014
CMC Biologics And Zymeworks Enter Into Agreement For Process Development And Clinical Manufacture Of Bi-Specific Antibody Product Candidate 9/3/2014
RegeneRx Biopharmaceuticals, Inc. (RGRX) Receives $1 Million Pursuant To Product License And Stock Purchase Agreement 9/3/2014
Infinity Pharmaceuticals Inc. (INFI) Enters Into Master Clinical Supply Agreement And Material Transfer Agreement With Roche (RHHBY) 9/3/2014
Rosetta Genomics Ltd. (ROSG) And H. Lee Moffitt Cancer Center & Research Institute Enter Into Strategic Alliance To Develop microRNA-Based Cancer Diagnostics 9/3/2014
Bristol-Myers Squibb Company (BMY) Gives Back Rights To Alder Biopharmaceuticals Inc.'s Promising Arthritis Drug Clazakizumab 9/2/2014
Ablynx (ABLYF) Signs Exclusive License Agreement With Eddingpharm (Cayman) Inc. To Develop And Commercialise Its Anti-Tnfa Nanobody In Greater China 9/2/2014
Amarillo Biosciences (AMAR) Initiates CLIA Development Of Alzheimer's Blood Diagnostic Lympro Test® At ICON Central Laboratories 9/2/2014
Chimerix, Inc. (CMRX) And Biomedical Advanced Research and Development Authority (BARDA) Announce Continued Partnership In The Development Of Brincidofovir For Smallpox 9/2/2014
Advanced Biological Laboratories SA (ABL) And Mayo Medical Laboratories Announce Collaboration And Licensing Agreements 9/2/2014
EMD Group (EMD Millipore Headquarters) And Massachusetts General Hospital Collaborate To Better Understand Systemic Lupus Erythematosus And Lupus Nephritis 9/2/2014
Intrexon Corporation Announces Exclusive Channel Collaboration With Sanofi (France) (SAN.PA) To Optimize Production For A Specific Family Of Active Pharmaceutical Ingredients 9/2/2014
CleveXel Pharma Partners With Guilin Pharmaceutical To Develop Two New Anti-Malarial Products 9/2/2014
Minomic: Collaboration With U.S. Partner For New Prostate Cancer Treatment 8/29/2014
22nd Century Group, Inc. Partner NASCO Products Enters Into Agreement With Smoker Friendly International 8/29/2014
Innovus Pharma Signs Exclusive Marketing And Distribution Agreement With Danalife Aps To Market And Distribute Zestra® For Alternative Markets 8/28/2014
Formal Transfer Of Global Rights For Tozadenant To BioTie Therapies Corp. Concluded 8/28/2014
BioTime (BTX) To Collaborate With The University of Wisconsin And Louvain University In Test Of Hystem®-Based Hydrogel For Vocal Fold Scarring 8/28/2014
Dow Microbial Control Forges Commercial Agreement With Xgenex For U.S. Sales Of Dow AOS Certified Technology 8/28/2014
Mafraq Hospital Improves Diabetic Care After University Collaboration 8/28/2014
United States Department Of Commerce Partners With Virocyt To Expand Asian Markets 8/28/2014
Atossa Genetics, Inc. (ATOS) Announces Commercial Partner for Laboratory Services Offered By The National Reference Laboratory For Breast Health, Inc. 8/28/2014
Amerigen Pharmaceuticals And The Ningbo MENOVO Pharmaceutical Co.,LTD., Today Announced They Had Entered Into A Collaboration Agreement Regarding The Development Of Generic Pharmaceuticals, Primarily Targeting The United States Market 8/27/2014
Drug Giants Merck & Co. (MRK) And Pfizer (PFE) Forge Cancer Pact 8/27/2014
LabSmith, Inc. Products Now Distributed In South Korea By Revodix, Inc. 8/27/2014
Tiny Biotech Advaxis, Inc. Inks Another Pact With Merck & Co. (MRK) To Test Immune Therapies Against Prostate Cancer 8/26/2014
ViveBio And Laboratory Procurement Services Sign Agreement For Distribution Of The ViveST Line Of Products 8/26/2014
Recipharm AB Forms New Collaboration With Isofol Medical AB To Exclusively Manufacture Modufolin® And Invests SEK 8 Million In The Company 8/26/2014
Bavarian Nordic (BAVA.CO) Receives Order From The Canadian Government To Supply IMVAMUNE® Smallpox Vaccine 8/26/2014
A*STAR, BCA And Hitachi, Ltd. (HIT) Pilot Plant Facilitates Research For Greener Buildings 8/26/2014
MRC Technology Negotiates License With Bio-Techne For MRC’s GOPAL Protein Synthesis Technology 8/26/2014
Concert Pharmaceuticals, Inc. (CNCE) Achieves $2 Million Milestone For AVP-786 Under AVANIR Pharmaceuticals (AVNR) Collaboration 8/26/2014
AB SCIEX And Dalton Pharma Services Collaborate To Advance Antibody-Drug Conjugate Analysis 8/26/2014
iBio, Inc. (IBIO) Enters Into $10 Million Common Stock Purchase Agreement With Aspire Capital 8/26/2014
Novozymes A/S (NVZMY) And Monsanto Company (MON) Showcase New Ag Innovations Expected To Increase Sustainability On The Farm 8/26/2014
Anavex Life Sciences Corp. (AVXL.OB) Selects The Alfred Hospital In Melbourne, Australia As Lead Site For Phase 2a Alzheimer's Clinical Trial 8/26/2014
Viropro Inc. (VPRO) Initiates Interim Debt Financing Of Up To $500,000 8/26/2014
Telik, Inc. (TELK) Receives $1.5 Million National Cancer Institute Contract To Develop Novel Antibody-Based PET Imaging Agent For Pancreatic Cancer 8/25/2014
Tauriga Sciences Inc. (TAUG) Executes Investment Banking Agreement With Tokyo, Japan Based Dragoon Capital Inc. 8/25/2014
Cardiome Pharma Corp. (COM.TO) Enters Commercialization Agreement With Eurolab Especialidades Medicinales For Brinavess™ In Argentina 8/25/2014
ViaCyte, Inc. (Formerly Known as Novocell, Inc.) Gains $20 Million Through Deal With Janssen Research & Development 8/22/2014
Sucampo Pharmaceuticals, Inc. (SCMP) Announces New Exclusive Global Manufacturing And Supply Agreement For Lubiprostone 8/22/2014
Luye In-Licenses China Rights To Cancer Drug From Korea's Hanmi Pharmaceutical, Co., Ltd 8/22/2014
Gallus Biopharmaceuticals, LLC Enters Agreement With Progenics Pharmaceuticals, Inc. (PGNX) For Manufacture Of Anti-PSMA Monoclonal Antibody 8/21/2014
Sarepta Therapeutics (SRPT) Enters Into Partnership With Flagship Biosciences LLC To Digitally Automate The Measurement Of Dystrophin, A Key Therapeutic Efficacy Marker For Muscular Dystrophy 8/21/2014
Antitope And University College London Enter Into A Research & Licence Agreement For The Generation Of Fully Humanized Antibodies Using Antitope’s Composite Human Antibody™ Technology 8/21/2014
Vensun Pharmaceuticals Enters Into Manufacturing, Supply and Distribution Agreement With ScieGen Pharmaceuticals, Inc. 8/21/2014
Massachusetts Biotechnology Council, Inc. Announces New Collaborations With Nature Publishing Group & Journal Of Commercial Biotechnology 8/21/2014
New Amsterdam Sciences Continues Pact With Dr. Jacob Finkelstein, PhD To Advance Pulmonary Fibrosis Research 8/21/2014
Angiocrine Bioscience Licenses New Stem Cell Technology From Weill Cornell Medical College 8/21/2014
DESY And IBM Corporation (IBM) Develop Big Data Architecture For Science 8/21/2014
Illumina, Inc. (ILMN) Partners With AstraZeneca PLC (AZN), Johnson & Johnson (JNJ) To Create New Genetic Tests For Cancer 8/21/2014
AstraZeneca PLC (AZN), Mitsubishi Tanabe Pharma Corporation Link Up For Diabetes Research 8/20/2014
Emergent BioSolutions (EBS), MorphoSys AG Strike Prostate Cancer Pact Worth $183 Million 8/20/2014
Novartis AG (NVS), Global Alliance For TB Drug Development Link Up To Search For TB Cure 8/20/2014
Crohn's and Colitis Foundation of America Release: Expanding IBD Research Through Collaboration 8/20/2014
Bristol-Myers Squibb Company (BMY) And Celgene (CELG) Enter Clinical Collaboration Agreement To Evaluate Immunotherapy And Chemotherapy Combination Regimen 8/20/2014
Global Institute Of Forensic Research Contracts With The Council Of State Governments To Provide Executive Bulletin Service 8/20/2014
Igenbio, Inc. And Genome Compiler Corp. Enter Into A Collaborative Agreement To Offer Synthetic Biology Solutions 8/20/2014
Roche (RHHBY) And Garvan Institute of Medical Research Partner To Develop Genomics Technologies For Targeted Epigenomic Analysis 8/19/2014
Mount Tam Biotechnologies Awarded Worldwide Exclusive License For Research Assets From the Buck Institute -- Advancing Promising Medical Compounds For The Treatment of Lupus Towards The FDA Drug Approval Process 8/19/2014
Evotec AG (EVTG.F) And Medicines for Malaria Venture (MMV) Announce A Long-Term Compound Management Collaboration 8/19/2014
A*STAR And Sumitomo Mitsui Banking Corporation Ink MOU To Support Japanese R&D Collaborations With Singapore 8/19/2014
CAPSUGEL And Cardax Pharmaceuticals Inc. To Collaborate On Development Of Proprietary Astaxanthin Products 8/19/2014
Biomedical Advanced Research and Development Authority (BARDA) Extends Contract With Cytori Therapeutics, Inc. (CYTX) For Burn Treatment, Deal Is Worth Up To $20.4 Million 8/19/2014
Vectura Group plc (VEC.L) Interim Management Statement 8/19/2014
Abbott Laboratories (ABT) Strikes $20 Million Pentagon Deal For Brain Injury Device 8/18/2014
Provectus Biopharmaceuticals Inc. Signs Memorandum Of Understanding With Sinopharm-China State Institute Of Pharmaceutical Industry, And Sinopharm A-THINK Pharmaceutical Co., Ltd. 8/18/2014
HUYA Bioscience International Announces Partnership With Changzhou Center For Biotech Development 8/18/2014
MMS Holdings, Inc. And Oncology Trials Insights Form Strategic Partnership To Deliver Comprehensive Oncology Support Services 8/18/2014
Immune Targeting Systems (ITS) Ltd. And WCCT Global Announce A New Influenza A H1N1 Virus To Support The Experimental Human Viral Challenge Model 8/18/2014
Expression Therapeutics Selects Advanced BioScience Laboratories, Inc. To Support Cell Line Development For Hemophilia A Factor VIII Infusion Therapy 8/18/2014
Pharpoint Research Wins Project Award From Otologic Pharmaceuticals 8/18/2014
ImmuDyne, Inc. (IMMD) Announces Launch Of Clinical Study 8/15/2014
Innovus Pharma And Consortia Health Initiate A Nationwide Marketing And Sales Campaign To U.S. Gynecologists For Zestra®, Clinically Proven For The Enhancement Of Female Arousal Desire And Satisfaction 8/15/2014
Amarillo Biosciences (AMAR) Exercises Option To License Intellectual Property From University Of Miami Bascom Palmer Eye Institute For Use Of MANF In Retinal Disorders 8/15/2014
Isis Pharmaceuticals, Inc. (ISIS) Earns $2 Million From The Advancement Of ISIS-SMN Rx In Children With Spinal Muscular Atrophy 8/15/2014
Ligand Pharmaceuticals Inc. (LGND) Signs Multi-Program Captisol® License Agreement With Avion Pharmaceuticals 8/14/2014
TNI BioTech Expands Partnership With Hubei Qianjiang Pharma 8/14/2014
Roche (RHHBY) Backs Out Of $600 Million Acromegaly Drug Development Deal With Chiasma Inc. 8/14/2014
RedHill Biopharma Ltd. (RDHL) Acquires Option For Phase 2 Pancreatic Cancer Drug RP101 8/13/2014



//-->